OLMEVAC M20/25

OLMEVAC M20/25 | Olmesartan Medoxomil 20 mg & Metoprolol Succinate 25 mg Extended Release Tablets

Description:
OLMEVAC M20/25 is a dual-action antihypertensive tablet combining Olmesartan Medoxomil 20 mg, an angiotensin II receptor blocker (ARB), and Metoprolol Succinate 25 mg, a cardioselective beta-blocker in extended-release form. It is prescribed for the effective management of high blood pressure (hypertension) and provides 24-hour blood pressure control.

This combination helps by relaxing blood vessels (Olmesartan) and reducing heart rate and workload (Metoprolol), making it ideal for patients who require multiple mechanisms to manage their blood pressure.

Key Features:
✅ Dual mechanism: ARB + Beta-blocker
✅ Extended-release formulation for sustained action
✅ Controls BP and reduces heart strain
✅ Once-daily dosage for improved compliance
✅ Helps reduce risk of heart attacks and strokes